Showing results (41-50 of 54) with videos related to
Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2024
Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP TrialVincent Camus, Catherine Thieblemont, Philippe Gaulard, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 21, 2019
Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results of the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS StudyCaroline Houillier, Luc Taillandier, Sylvain Dureau, et al.British Journal of Haematology|November 9, 2019
Lenalidomide maintenance for diffuse large B-cell lymphoma patients responding to R-CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC studyCatherine Thieblemont, Susannah Howlett, René-Olivier Casasnovas, et al.Hemasphere|May 8, 2026
Outcomes and salvage strategies for large B-cell lymphoma progressing after second-line CAR T-cell therapy: A DESCAR-T study from the LYSA groupPierre Sesques, Guillaume Manson, Guillaume Cartron, et al.Journal of Hematology & Oncology|August 6, 2024
Novel prognostic scoring systems for severe CRS and ICANS after anti-CD19 CAR T cells in large B-cell lymphomaPierre Sesques, Amy A Kirkwood, Mi Kwon, et al.American Journal of Hematology|April 2, 2024
Involvement of the JAK-STAT pathway in the molecular landscape of tyrosine kinase fusion-negative hypereosinophilic syndromes: A nationwide CEREO studyMatthieu Groh, Laurène Fenwarth, Mathilde Labro, et al.Blood Advances|October 24, 2023
Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohortHervé Ghesquières, Fanny Cherblanc, Aurélien Belot, et al.Haematologica|May 28, 2021
Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide: an international collaborative studySabine Kayser, Richard F Schlenk, Delphine Lebon, et al.Bone Marrow Transplantation|April 15, 2022
Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life-experience of the French NetworkLaurence Schenone, Caroline Houillier, Marie Laure Tanguy, et al.Blood|March 31, 2026
Lenalidomide plus rituximab for previously untreated advanced follicular lymphoma: the 10-year RELEVANCE trial analysisNicolas Gower, Pierre Feugier, Jason R Westin, et al.Pageof 6